Literature DB >> 16195370

Ischemic preconditioning modulates the expression of several genes, leading to the overproduction of IL-1Ra, iNOS, and Bcl-2 in a human model of liver ischemia-reperfusion.

Alain Barrier1, Natalia Olaya, Franck Chiappini, François Roser, Olivier Scatton, Cédric Artus, Brigitte Franc, Sandrine Dudoit, Antoine Flahault, Brigitte Debuire, Daniel Azoulay, Antoinette Lemoine.   

Abstract

Ischemia triggers an inflammatory response that precipitates cell death during reperfusion. Several studies have shown that tissues are protected by ischemic preconditioning (IP) consisting of 10 min of ischemia followed by 10 min of reperfusion just before ischemia. The molecular basis of this protective effect is poorly understood. We used cDNA arrays (20K) to compare global gene expression in liver biopsies from living human liver donors who underwent IP (n=7) or not (n=7) just before liver devascularization. Microarray data were analyzed using pairedt test with a type I error rate fixed at alpha = 2.5 10(6) (Bonferroni correction). We found that 60 genes were differentially expressed (36 over- and 24 underexpressed in preconditioning group). After IP, the most significantly overexpressed gene was IL-1Ra. This was confirmed by immunoblotting. Differentially expressed were genes involved in apoptosis (NOD2, ephrin-A1, and calpain) and in the carbohydrate metabolism. A significant increase in the amount of the anti-apoptotic protein Bcl-2 in preconditioned livers but no change in the cleavage of procaspase-3, -8, and -9 was observed. We also observed an increase in the amount in the inducible nitric oxide synthase. Therefore, the benefits of IP may be associated with the overproduction of IL-1Ra, Bcl-2, and NO countering the proinflammatory and proapoptotic effects generated during ischemia-reperfusion.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16195370     DOI: 10.1096/fj.04-3445com

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  21 in total

1.  Transcriptional analysis of infiltrating T cells in kidney ischemia-reperfusion injury reveals a pathophysiological role for CCR5.

Authors:  Gang Jee Ko; Douglas Linfert; Hye Ryoun Jang; Elizabeth Higbee; Tonya Watkins; Chris Cheadle; Manchang Liu; Lorraine Racusen; Dmitry N Grigoryev; Hamid Rabb
Journal:  Am J Physiol Renal Physiol       Date:  2011-12-07

Review 2.  Molecular mechanisms of liver preconditioning.

Authors:  Elisa Alchera; Caterina Dal Ponte; Chiara Imarisio; Emanuele Albano; Rita Carini
Journal:  World J Gastroenterol       Date:  2010-12-28       Impact factor: 5.742

Review 3.  Role of ischaemic preconditioning in liver regeneration following major liver resection and transplantation.

Authors:  D Gomez; S Homer-Vanniasinkam; A M Graham; K R Prasad
Journal:  World J Gastroenterol       Date:  2007-02-07       Impact factor: 5.742

4.  Ischaemic preconditioning of the graft in adult living related right lobe liver transplantation: impact on ischaemia-reperfusion injury and clinical relevance.

Authors:  Paola Andreani; Emir Hoti; Sofia de la Serna; Davide degli Esposti; Mylène Sebagh; Antoinette Lemoine; Philippe Ichai; Fauzi Saliba; Denis Castaing; Daniel Azoulay
Journal:  HPB (Oxford)       Date:  2010-09       Impact factor: 3.647

5.  Ischemic preconditioning attenuates lactate release by the liver during hepatectomies under vascular control: a case-control study.

Authors:  Kassiani Theodoraki; Nikolaos Arkadopoulos; George Fragulidis; Ioannis Vassiliou; Maria Markatou; Agatha Pafiti; Georgia Kostopanagiotou; Vassilios Smyrniotis
Journal:  J Gastrointest Surg       Date:  2011-02-11       Impact factor: 3.452

6.  Ischemic preconditioning confers antiapoptotic protection during major hepatectomies performed under combined inflow and outflow exclusion of the liver. A randomized clinical trial.

Authors:  Nikolaos Arkadopoulos; Georgia Kostopanagiotou; Kassiani Theodoraki; Charalambos Farantos; Theodosios Theodosopoulos; Vaia Stafyla; John Vassiliou; Dionyssios Voros; Agathi Pafiti; Vassilios Smyrniotis
Journal:  World J Surg       Date:  2009-09       Impact factor: 3.352

7.  Recent advances in liver preconditioning: Thyroid hormone, n-3 long-chain polyunsaturated fatty acids and iron.

Authors:  Virginia Fernández; Gladys Tapia; Luis A Videla
Journal:  World J Hepatol       Date:  2012-04-27

8.  The strategy of combined ischemia preconditioning and salvianolic acid-B pretreatment to prevent hepatic ischemia-reperfusion injury in rats.

Authors:  Rui Kong; Yue Gao; Bei Sun; Hua Chen; Gang Wang; Xiuyun Wang; Hong Zhu; Shangha Pan; Dongbo Xue; Hongchi Jiang
Journal:  Dig Dis Sci       Date:  2009-12       Impact factor: 3.199

9.  Ischemic preconditioning-induced neuroprotection is associated with differential expression of IL-1beta and IL-1 receptor antagonist in the ischemic cortex.

Authors:  Jin A Shin; Eun-Mi Park; Ji-Seung Choi; Sun-Mi Seo; Jihee Lee Kang; Kyung-Eun Lee; Sunghee Cho
Journal:  J Neuroimmunol       Date:  2009-07-09       Impact factor: 3.478

Review 10.  Remote ischemic preconditioning and renoprotection: from myth to a novel therapeutic option?

Authors:  Natig Gassanov; Amir M Nia; Evren Caglayan; Fikret Er
Journal:  J Am Soc Nephrol       Date:  2013-12-05       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.